- By FYH News Team
[ad_1]
doi: 10.1001/jamadermatol.2023.4643.
Online ahead of print.
Affiliations
Affiliations
- 1 Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston.
- 2 McGovern Medical School, The University of Texas Health Science Center at Houston.
- 3 Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia.
- 4 Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
- 5 Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston.
Item in Clipboard
Lucy J Navsaria et al.
JAMA Dermatol.
.
Display options
Format
doi: 10.1001/jamadermatol.2023.4643.
Online ahead of print.
Affiliations
- 1 Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston.
- 2 McGovern Medical School, The University of Texas Health Science Center at Houston.
- 3 Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia.
- 4 Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
- 5 Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston.
Item in Clipboard
Display options
Format
No abstract available
Plain language summary
This cohort study examines raw and age-adjusted differences in the incidence of keratinocyte carcinoma among Medicare beneficiaries by race and ethnicity.
[ad_2]
Source link
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
- Victor Mejia
- Victor Mejia
















